Source: International Congress 2016 – New genomic targets in pulmonary disease
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
Malamati Vreka (Munich, Germany), Antonia Marazioti, Malamati Vreka, Anastasios Giannou, Nikolaos Kanellakis, Magda Spella, Theodora Agalioti, Ioanna Giopanou, Georgios Stathopoulos. LSC Abstract – Host-environmental IL-1b drives mutant KRAS-IKKa addiction in malignant pleural effusion. Eur Respir J 2016; 48: Suppl. 60, 1783

Member's Comments

No comment yet.

Related content which might interest you: The value of IL6 in differentiation between malignant and non malignant pleural effusion Source: Annual Congress 2009 - Diagnosis of pleural effusions and rare tumours experience Year: 2009 LSC Abstract – A requirement for mast cells in malignant pleural effusion Source: International Congress 2015 – Malignant pleural effusions and mesothelioma Year: 2015 Clinical role of pleural effusion MMP-3 levels in malignant pleural mesothelioma Source: Annual Congress 2012 - Biology and treatment of malignant pleural effusions Year: 2012 Malignant pleural effusion cells show aberrant glucose metabolism gene expression Source: Eur Respir J 2011; 37: 1453-1465 Year: 2011 Interleukin-8 and other mediators are related to tumour burden in malignant pleural effusions (MPE) Source: Eur Respir J 2007; 30: Suppl. 51, 103s Year: 2007 Interleukin-16 in tuberculous and malignant pleural effusions Source: Eur Respir J 2005; 25: 605-611 Year: 2005 Talc mediates angiostasis in malignant pleural effusions via endostatin induction Source: Eur Respir J 2007; 29: 761-769 Year: 2007 Expression of human mammaglobin gene in pleural effusion of patients affected by malignant pleural mesothelioma (MM) Source: Eur Respir J 2004; 24: Suppl. 48, 81s Year: 2004 Pentraxin-3: A novel biomarker for the differentiation of parapneumonic effusion and malignant pleural effusion Source: Annual Congress 2012 - Novelties in clinical management of thoracic diseases: from diaphragm to pleura Year: 2012 Accuracy of pleural fluid c-reactive protein in differentiating between tuberculous and malignant pleural effusions: a meta-analysis Source: International Congress 2019 – Tuberculosis and comorbidities Year: 2019 Management of malignant pleural effusions Source: Guideline 2001 Year: 2001 Management of malignant pleural effusions Source: Eur Respir J 2001; 18: 402-419 Year: 2001 Management of malignant pleural effusions Source: ERS Skills course: Multi-disciplinary care in thoracic oncology Year: 2019 Management of malignant pleural effusion Source: Eur Respir J 2001; 18: Suppl. 33, 397s Year: 2001 Correlation between pleural fluid cytological yield and pleural tumour burden in malignant pleural effusions Source: Annual Congress 2010 - 100 years of thoracoscopy: still room for improvement? Year: 2010 Diagnostic value of pleural fluid angiopoietin-2 (Ang-2) levels, to differentiate malignant pleural effusions from benign pleural effusions Source: International Congress 2016 – Mesothelioma and malignant pleural disease Year: 2016 C-reactive protein in differentiation between tuberculous and malignant pleural effusions Source: Annual Congress 2011 - Clinical challenges in tuberculosis Year: 2011 Is it important to determine pleural fluid amylase in patients with malignant pleural effusions? Source: Eur Respir J 2007; 30: Suppl. 51, 565s Year: 2007